drugset
drugset / Trial / NCT03662477

Effect of NK Cell Immunotherapy on Advanced Lung Adenocarcinoma Adenocarcinoma With EGFR Mutation

NCT03662477 ↗

Phase 0 Unknown 10 enrolled Shenzhen Fifth People's Hospital
RandomizedSingle-groupSingle-blindTreatment

Summary

This study was attempted to investigate the efficiency of NK cells immunotherapy on non-small cell lung cancer with and without EGFR mutation, and evaluated response rate (RR) and the progression-free survival (PFS).

Timeline

Start
2018-01-01
Primary completion
2019-12-20
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject TROCULEUCEL Cell therapy — —

Indications

No indication recorded.